BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Hepatology

The World Journal of Hepatology (WJH) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of hepatology.  It was launched on October 31, 2009 and is published monthly (36 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage hepatologists worldwide to submit manuscripts to the WJH describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJH are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks.The WJH’s acceptance rate: 51%. Submit here >>

2017 Published Issues
11 10 9 8 7 6 5 4 3 2 1
Editors-in-Chief

Clara Balsano, PhD, Professor; Wan-Long Chuang, MD,PhD, Doctor,Professor

Indexing/Abstracting

PubMed, PubMed Central, Emerging Sources Citation Index(Web of Science), and Scopus.

Journal Metrics

SJR (SCImago Journal Rank) (2015): 0.858; IPP (Impact per Publication) (2015): 2.730; SNIP (Source Normalized Impact per Paper) (2015): 1.206; and CiteScore (2015) 3.19.

ISSN

1948-5182 (online)

Review
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management  
George Cholankeril, Ronak Patel, Sandeep Khurana, Sanjaya K Satapathy
World J Hepatol 9(11):533-543. Published online Apr 18, 2017. doi: 10.4254/wjh.v9.i11.533
Retrospective Study
Efficacy and safety of dual therapy with daclatasvir and asunaprevir in elderly patients  
Kazuo Tarao, Katsuaki Tanaka, Akito Nozaki, Akira Sato, Toshiya Ishii, Hirokazu Komatsu, Takaaki Ikeda, Tatsuji Komatsu, Shozo Matsushima, Kenji Oshige
World J Hepatol 9(11):544-550. Published online Apr 18, 2017. doi: 10.4254/wjh.v9.i11.544
Observational Study
Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection  
Kian Bichoupan, Neeta Tandon, Valerie Martel-Laferriere, Neal M Patel, David Sachs, Michel Ng, Emily A Schonfeld, Alexis Pappas, James Crismale, Alicia Stivala, Viktoriya Khaitova, Donald Gardenier, Michael Linderman, William Olson, Ponni V Perumalswami, Thomas D Schiano, Joseph A Odin, Lawrence U Liu, Douglas T Dieterich, Andrea D Branch
World J Hepatol 9(11):551-561. Published online Apr 18, 2017. doi: 10.4254/wjh.v9.i11.551
Case Report
18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report  
Willy Liu, Jean Delwaide, Noella Bletard, Philippe Delvenne, Paul Meunier, Roland Hustinx, Olivier Detry
World J Hepatol 9(11):562-566. Published online Apr 18, 2017. doi: 10.4254/wjh.v9.i11.562